GeneDx Holdings Corp. (WGS)
66.20
+0.68
(+1.04%)
USD |
NASDAQ |
Apr 02, 16:00
66.23
+0.03
(+0.05%)
After-Hours: 20:00
GeneDx Holdings Research and Development Expense (TTM) : 70.69M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Illumina, Inc. | 950.00M |
| Natera, Inc. | 624.11M |
| Guardant Health, Inc. | 364.19M |
| Delcath Systems, Inc. | 29.25M |
| CytoSorbents Corp. | 5.086M |